WuXi AppTec Co., Ltd.
HKSE: 2359.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Ge Li
- Employees
- 39,414
- Headquarters
- Shanghai, China
- IPO year
- 2018
- Market cap
- HK$388.8B
- Website
- https://www.wuxiapptec.com
Loading 2359…
Loading profile data…Frequently asked questions about 2359
What does WuXi AppTec Co., Ltd. (2359.HK) do?
WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi C...
Where does 2359.HK trade?
WuXi AppTec Co., Ltd. (2359.HK) trades on the Hong Kong Stock Exchange.
What sector is 2359.HK in?
WuXi AppTec Co., Ltd. (2359.HK) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of WuXi AppTec Co., Ltd.?
Ge Li is the chief executive officer of WuXi AppTec Co., Ltd. (2359.HK).
Where is WuXi AppTec Co., Ltd. headquartered?
WuXi AppTec Co., Ltd. is headquartered in China.
Does 2359.HK pay a dividend?
Yes — WuXi AppTec Co., Ltd. (2359.HK) paid a trailing twelve-month dividend of HKD 3.62 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 2359.HK go public?
WuXi AppTec Co., Ltd. (2359.HK) completed its initial public offering in 2018.